Candriam S.C.A. Acadia Pharmaceuticals Inc Transaction History

Candriam S.C.A.

$15.4 Billion
Q1 2024

A detailed history of Candriam S.C.A. transactions in Acadia Pharmaceuticals Inc stock. As of the latest transaction made, Candriam S.C.A. holds 405,751 shares of ACAD stock, worth $6.59 Million. This represents 0.05% of its overall portfolio holdings.

Number of Shares

405,751

Holding current value

$6.59 Million

% of portfolio

0.05%

13 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2024 May 03, 2024	BUY	$17.79 - $30.86 $7.22 Million - $12.5 Million	405,751 New	405,751 $7.5 Million
Q2 2022 Aug 03, 2022	SELL	$13.01 - $27.22 $3 Million - $6.27 Million	-230,417 Closed	0 $0
Q1 2022 May 13, 2022	SELL	$20.94 - $27.5 $945,294 - $1.24 Million	-45,143 Reduced 16.38%	230,417 $5.58 Million
Q2 2021 Jul 20, 2021	SELL	$19.4 - $27.42 $452,563 - $639,653	-23,328 Reduced 7.8%	275,560 $6.72 Million
Q4 2020 Jan 22, 2021	SELL	$41.04 - $56.79 $414,996 - $574,260	-10,112 Reduced 3.27%	298,888 $16 Million

Q3 2020 Oct 19, 2020	BUY	$36.42 - $57.0 $2.55 Million - $3.99 Million	70,000 Added 29.29%	309,000 $12.7 Million
Q2 2020 Jul 23, 2020	BUY	$39.26 - $52.73 $6.24 Million - $8.38 Million	159,000 Added 198.75%	239,000 $11.6 Million
Q4 2019 Jan 21, 2020	BUY	$36.21 - $51.4 $2.9 Million - $4.11 Million	80,000 New	80,000 $3,000
Q1 2019 May 02, 2019	SELL	$16.17 - $27.38 $2.81 Million - $4.76 Million	-173,700 Closed	0 $0
Q4 2018 Feb 14, 2019	BUY	$14.32 - $22.92 $544,160 - $870,960	38,000 Added 28.0%	173,700 $2.81 Million
Q3 2018 Nov 07, 2018	BUY	$13.03 - $21.81 $48,211 - $80,697	3,700 Added 2.8%	135,700 $2.82 Million
Q2 2018 Aug 14, 2018	BUY	$15.07 - $22.34 $828,850 - $1.23 Million	55,000 Added 71.43%	132,000 $2.02 Million
Q3 2017 Nov 03, 2017	BUY	$29.49 - $38.37 $2.27 Million - $2.95 Million	77,000	77,000 $2.9 Million

Others Institutions Holding ACAD

# of Institutions

299

Shares Held

158M

Call Options Held

1.88M

Put Options Held

688K

View Full List

About ACADIA PHARMACEUTICALS INC

Ticker ACAD
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 161,843,008
Market Cap $2.63B
Description
ACADIA Pharmaceuticals Inc., a biopharmaceutical company, focuses on the development and commercialization of small molecule drugs that address unmet medical needs in central nervous system disorders. The company offers NUPLAZID (pimavanserin) for the treatment of hallucinations and delusions associated with Parkinson's disease psychosis. It's p...

More about ACAD

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Candriam S.C.A., based on Form 13F filings with the SEC.

News

Stay updated on Candriam S.C.A. with notifications on news.

Account